Winn CDA Application Is Now Open!!! Click Here!

Diversity in Clinical Trials Career Development Program
  • Home
  • About Us
  • Winn CDA
    • The Need
    • Our Vision
    • Goals
    • Program Model
    • Program Requirements
    • Key Program Elements
    • Application Information
  • Winn CIPP
    • The Need
    • Our Mission and Vision
    • Goals
    • Program Model
    • Key Program Elements
    • Application Information
  • Informational Webinars
  • Nat'l Advisory Committee
  • In The News
  • Contact Us
  • FAQs
  • More
    • Home
    • About Us
    • Winn CDA
      • The Need
      • Our Vision
      • Goals
      • Program Model
      • Program Requirements
      • Key Program Elements
      • Application Information
    • Winn CIPP
      • The Need
      • Our Mission and Vision
      • Goals
      • Program Model
      • Key Program Elements
      • Application Information
    • Informational Webinars
    • Nat'l Advisory Committee
    • In The News
    • Contact Us
    • FAQs
Diversity in Clinical Trials Career Development Program
  • Home
  • About Us
  • Winn CDA
    • The Need
    • Our Vision
    • Goals
    • Program Model
    • Program Requirements
    • Key Program Elements
    • Application Information
  • Winn CIPP
    • The Need
    • Our Mission and Vision
    • Goals
    • Program Model
    • Key Program Elements
    • Application Information
  • Informational Webinars
  • Nat'l Advisory Committee
  • In The News
  • Contact Us
  • FAQs

why we created the program

Definition of Diversity in Clinical Trials

Definition of Diversity in Clinical Trials

Definition of Diversity in Clinical Trials

• Engage a patient population that mirrors the epidemiology of the disease studied


• Assure the ecosystem around the trials reflects diverse populations being served. Includes research sites, principal investigators, and extended care teams


• Design in inclusivity from start

Current State of Clinical Trials

Definition of Diversity in Clinical Trials

Definition of Diversity in Clinical Trials

• Black Americans represent 13% of the US population but reflect only about 4% of participants in clinical trials


• Hispanics represent 16% of the US population but only about 3% of clinical trial participants


• In general 80% of patients taking part in clinical trials are white*  

Benefits of Diversity in Clinical Trials

Definition of Diversity in Clinical Trials

Benefits of Diversity in Clinical Trials

• Better Science. Safety and efficacy of new medicines should be assessed in the patients with the condition


• Personalized Medicine. Understanding the range of different responses to treatments based on genetic variations


• Data. Better inform treatment decisions by making new options available to patients


• Address disparity and inequity

(1)*CDC Heart Disease Facts https://www.cdc.gov/heartdisease/facts.htm

(2)Cancer Facts & Figures 2020 https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf

(3)The Burden of Cancer in Asian Americans: A Report of National Mortality Trends by Asian Ethnicity http://cebp.aacrjournals.org/content/25/10/1371

Copyright © 2022

Robert A. Winn Diversity in Clinical Trials Award Program. All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept